Your own stem cells could rebuild a dying hip bone

NCT ID NCT07101562

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new way to treat early-stage avascular necrosis (bone death) of the hip. Doctors take a patient's own bone marrow stem cells, grow them on a special bone scaffold in the lab, and then implant this 'tissue-engineered bone' into the damaged area. The goal is to see if this can regrow healthy bone, relieve pain, and improve hip function, potentially avoiding the need for a hip replacement. The trial will enroll 30 adults aged 20 to 65 with non-traumatic early-stage femoral head necrosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tissue-engineered bone made from the patient's own bone marrow stem cells

What this could lead to

If it works, this could offer a way to repair damaged bone in the hip and delay or avoid the need for a total hip replacement.

What could go wrong

This is a small early study with only 30 people, so results may not apply to everyone. There is also a risk the treatment may not prevent further collapse of the hip joint.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS OF FEMUR HEAD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis of femoral head, primary, 1 familial avascular necrosis of femoral head secondary non-traumatic avascular necrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Xinxiang Medical College

    RECRUITING

    Xinxiang, Henan, 453000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••